Eva Dombi, M.D.

Eva Dombi, M.D.
Research Biologist
Head, Pet Section Imaging Program

Team Member of:

Dr. Dombi leads the PET Section Imaging Program. She has had a critical role in the development and validation of a novel method of image analysis for neurofibromatosis type 1 (NF1) tumors and plexiform neurofibromas which is now used in most ongoing clinical trials nationwide to assess the primary endpoint of disease progression.

Areas of Expertise
1) imaging, 2) image analysis

Contact Info

Eva Dombi, M.D.
Center for Cancer Research
National Cancer Institute
Building 10, Room 1-5750
Bethesda, MD 20892-1101
Ph: 301-451-7023
dombie@mail.nih.gov

Dr. Dombi received her M.D. at the Semmelweis University, Budapest, Hungary. She completed her pediatric residency training in Budapest, Hungary, prior to moving with her family to the United States. She has been a PET Section member since 2002. Dr. Dombi leads the PET Section Imaging Program. One of her many roles has been the support of research efforts related to the development of novel medical treatments for children and young adults with neurofibromatosis type 1 (NF1) and plexiform neurofibromas. Dr. Dombi had a critical role in the development and validation of a novel method of image analysis for these tumors, which is now used in most ongoing clinical trials nationwide to assess the primary endpoint of disease progression. Dr. Dombi performs central response evaluation of plexiform neurofibromas using volumetric MRI on multiple clinical trials. In addition, Dr. Dombi has several ongoing collaborations with extramural investigators.